%0 Journal Article
%T Pharmacokinetics of Hizentra at Weekly vs. Biweekly Dosing Regimens
%A Elie Haddad
%A Gautam Baheti
%A Hugo Chapdelaine
%A Jutta Hofmann
%A Michael Tortorici
%A Michaela Praus
%A Mikhail Rojavin
%J Journal of Allergy and Clinical Immunology
%D 2018
%R 10.1016/j.jaci.2017.12.062
%X Pharmacokinetics (PK) of the 20% subcutaneous immunoglobulin (SCIG) Hizentra in patients
with primary immune deficiency (PID) is well established for weekly dosing. However,
PK data of SCIG infusions every 2 weeks (biweekly) are not available
%U https://www.jacionline.org/article/S0091-6749(17)31962-0/abstract